95715-85-8

Basic information

• Product Name: BOC-D-SER-OME
• Synonyms: N-(TERT-BUTOXYCARBONYL)-D-SERINE METHYL ESTER;BOC-D-SERINE METHYL ESTER;BOC-D-SER-OME;D-Serine, N-[(1,1-dimethylethoxy)carbonyl]-, methyl ester (9CI);N-(TERT-BBUTOXYCARBONYL)-L-SERINE METHYL ESTER;BOC-D-SERINE METHYLESTER OIL;N-BOC-D-serine methylester;N-BOC-D-ser-methylester
• CAS NO: 95715-85-8
• Molecular Formula: C₉H₁₇NO₅
• Molecular Weight: 219.23
• EINECS: 1533716-785-6
• Product Categories: N-BOC;Heterocyclic Compounds;Serine [Ser, S];Amino Acid Derivatives;Peptide Synthesis;Serine;Amino Acids & Derivatives;Chiral Reagents;Intermediates;Pyridines
• Mol File: 95715-85-8.mol
• Article Data: 49

Chemical Properties

• Boiling Point: 215 °C(lit.)
• Flash Point: >230 °F
• Appearance: Colorless to yellow/Liquid
• Density: 1.08 g/mL at 25 °C(lit.)
• Vapor Pressure: 1.94E-06mmHg at 25°C
• Refractive Index: n20/D 1.453(lit.)
• Storage Temp.: Store at 0-5°C
• Solubility: Chloroform, Methanol
• PKA: 10.70±0.46(Predicted)
• CAS DataBase Reference: BOC-D-SER-OME(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-D-SER-OME(95715-85-8)
• EPA Substance Registry System: BOC-D-SER-OME(95715-85-8)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• WGK Germany: 3
• Hazardous Substances Data: 95715-85-8(Hazardous Substances Data)

Usage

Chemical Properties

colorless to light yellow liquid

Uses

Protected D-Serine.

InChI:InChI=1/C9H17NO5/c1-9(2,3)15-8(13)10-6(5-11)7(12)14-4/h6,11H,5H2,1-4H3,(H,10,13)/t6-/m1/s1

Upstream product

• 186581-53-3 diazomethane 
• 3262-72-4 (R)-N-tert-butoxycarbonyl serine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 2104-89-4 D-serine methyl ester 
• 67-56-1 methanol 
• 312-84-5 D-Serine 
• 74-88-4 methyl iodide 
• 2788-84-3 (S)-serine methyl ester 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 58632-95-4 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile 
• 5874-57-7 R-(-)-serine methyl ester hydrochloride 

Downstream Products

• 112418-19-6 (R)-2-N-tert-butoxycarbonylamino-3-(tert-butyldimethylsilyloxy)propionic acid methyl ester 
• 108149-60-6 methyl [(4R)-3-(tert-butoxycarbonyl)-2,2-dimethyl-1,3-oxazolidin-4-yl]carboxylate 
• 95715-86-9 (S)-2,2-dimethyl-oxazolidine-3,4-dicarboxylic acid 3-tert-butyl ester 4-methyl ester 
• 721927-59-9 tert-butyl [(2R)-1-hydroxy-3-methoxypropan-2-yl]carbamate 
• 469886-48-4 (2S)-[1-(tert-butyldiphenylsilanyloxymethyl)-2-hydroxyethyl]carbamic acid tert-butyl ester 
• 353520-92-0 2-(2-benzyloxycarbonylamino-3-{3-[3-(2-tert-butoxycarbonylamino-1-hydroxy-3-triisopropylsilanyloxy-propyl)-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-7-yl]-4-methoxy-phenyl}-propionylamino)-succinamic acid tert-butyl ester 
• 353520-93-1 2-(2-benzyloxycarbonylamino-3-{3-[3-(2-tert-butoxycarbonylamino-1-hydroxy-3-triisopropylsilanyloxy-propyl)-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-7-yl]-4-methoxy-phenyl}-propionylamino)-succinamic acid tert-butyl ester 
• 353520-90-8 2-(2-benzyloxycarbonylamino-3-{3-[3-(2-tert-butoxycarbonylamino-3-triisopropylsilanyloxy-propylidene)-2-oxo-2,3-dihydro-1H-indol-7-yl]-4-methoxy-phenyl}-propionylamino)-succinamic acid tert-butyl ester 
• 353520-94-2 2-(2-benzyloxycarbonylamino-3-{3-[3-(2-tert-butoxycarbonylamino-3-hydroxy-propylidene)-2-oxo-2,3-dihydro-1H-indol-7-yl]-4-methoxy-phenyl}-propionylamino)-succinamic acid tert-butyl ester 
• 353520-95-3 2-benzyloxycarbonylamino-3-{3-[3-(2-tert-butoxycarbonylamino-3-triisopropylsilanyloxy-propylidene)-2-oxo-2,3-dihydro-1H-indol-7-yl]-4-methoxy-phenyl}-propionic acid methyl ester 
• 353520-86-2 2-benzyloxycarbonylamino-3-{3-[3-(2-tert-butoxycarbonylamino-3-triisopropylsilanyloxy-propylidene)-2-oxo-2,3-dihydro-1H-indol-7-yl]-4-methoxy-phenyl}-propionic acid methyl ester 
• 328086-54-0 (2E,4S)-4-(tert-butoxycarbonylamino)-5-[(3'S)-2'-oxo-3'-pyrrolidinyl]-2-pentenoic acid ethyl ester 
• 249736-45-6 [2-hydroxy-1S-(2-oxopyrrolidin-3S-ylmethyl)ethyl]carbamic acid tert-butyl ester 
• 651031-17-3 3-[(2S)-2-(tert-butoxycarbonylamino)-3-(benzyloxy)propanoxy]-(2S)-1-(tert-butyldiphenylsilyloxy)-2-(methanesulfonyloxy)propane 

Relevant articles and documents

APPLICATION OF MONOCYCLIC BETA-LACTAM COMPOUND IN PHARMACY

An application of a compound represented by formula (I) and pharmaceutically acceptable salts thereof in preparation of a drug for treating pneumonia.

Radical-Mediated Acyl Thiol-Ene Reaction for Rapid Synthesis of Biomolecular Thioester Derivatives

The thiol-ene ‘click’ reaction has emerged as a versatile process for carbon–sulfur bond formation with widespread applications in chemical biology, medicinal chemistry and materials science. Thioesters are key intermediates in a wide range of synthetic and biological processes and efficient methods for their synthesis are of considerable interest. Herein, we report the first examples of acyl-thiol-ene (ATE) for the synthesis of biomolecular thioesters, including peptide, lipid and carbohydrate derivatives. A key finding is the profound effect of the amino acid side chain on the outcome of the ATE reaction. Furthermore, radical generated thioesters underwent efficient S-to-N acyl transfer and desulfurisation to furnish ‘sulfur-free’ ligation products in an overall amidation process with diverse applications for chemical ligation and bioconjugation.

A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration

Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need to develop more efficacious NP attenuating drugs. Activation of the type 1 lysophosphatidic acid (LPA1) receptor is a crucial factor in the initiation of NP. Hence, it is conceivable that a functional antagonism strategy could lead to NP mitigation. Here we describe a new series of LPA1 agonists among which derivative (S)-17 (UCM-05194) stands out as the most potent and selective LPA1 receptor agonist described so far (Emax = 118%, EC50 = 0.24 μM, KD = 19.6 nM; inactive at autotaxin and LPA2-6 receptors). This compound induces characteristic LPA1-mediated cellular effects and prompts the internalization of the receptor leading to its functional inactivation in primary sensory neurons and to an efficacious attenuation of the pain perception in an in vivo model of NP.